财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(AFMD)
公司资讯
finviz | 2022年05月27日 05:05
Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
finviz | 2022年05月26日 18:30
Affimed to Present at the 2022 Jefferies Healthcare Conference
finviz | 2022年05月26日 03:00
Affimed N.V. (AFMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finviz | 2022年05月24日 18:30
Affimed to Report First Quarter 2022 Financial Results & Corporate Update on June 1, 2022
finviz | 2022年05月24日 18:30
Affimed Announces Annual General Meeting of Shareholders
finviz | 2022年05月16日 20:00
Affimed Presents Data on Innate Cell Engagers AFM24 and AFM28 at 19th Meeting of the Society for Natural Immunity
finviz | 2022年05月14日 20:06
What Percentage Of Affimed N.V. (NASDAQ:AFMD) Shares Do Insiders Own?
finviz | 2022年05月12日 22:31
Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)
finviz | 2022年05月07日 04:02
Affimed Provides Update on ASCO AFM13-104 Oral Presentation
finviz | 2022年04月28日 05:21
CORRECTING and REPLACING -- Affimed N.V.
finviz | 2022年04月28日 04:05
Affimed Announces Clinical Update and Trial in Progress Posters at the Annual Meeting of the American Association for Cancer Research (ASCO)
finviz | 2022年04月18日 23:28
Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters Option to Purchase Additional Shares
finviz | 2022年04月13日 10:02
Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares
finviz | 2022年04月13日 04:03
Affimed Announces Proposed Public Offering of Common Shares
finviz | 2022年04月12日 03:59
Affimed Touts Encouraging Patient Responses For Its NK Cell Therapy In Lymphoma Settings
finviz | 2022年04月12日 00:22
Why Affimed Stock Is Heating Up Today
首页
 
上页
下页